Worry about the return of people returning to their hometowns during the Spring Festival has triggered the COVID-19 pandemic again. Nuvaxovid

Focus
Worry about the return of people returning to their hometowns during the Spring Festival has triggered the COVID-19 pandemic again. Nuvaxovid

The annual holiday is coming soon, and the expected wave of returning home, traveling, and reunion activities such as gatherings in public places may increase the potential risk of COVID-19 infection. While epidemic respiratory diseases are still prevalent, people are worried about being exposed to the risk of infection at any time. . Therefore, the Ministry of Health and Welfare introduced approximately more than 165,000 doses of the Nuvaxovid XBB1.5 vaccine on the eve of the New Year holiday, and encouraged the public to get vaccinated to enhance their body protection.

The new coronavirus variant XBB.1.5 has “immune evasion” and the number of secondary infections remains high

The new variant of COVID-19, XBB.1.5, which became prevalent last year, is highly contagious and has become the mainstream variant in Europe, the United States, and Asia. Fortunately, after risk assessment, the infection symptoms are not much different from those of other mutant strains. Cold symptoms such as runny nose, fever, sore throat, and cough are still the main symptoms. However, for people with poor immunity, there are still moderate to severe cases. Risk of Symptoms. In addition, the World Health Organization (WHO) reminds that the high transmissibility of the XBB.1.5 variant and its “immune evasion” make people who have recovered from the infection have a high chance of being infected again.

Therefore, the World Health Organization (WHO) recommends that countries use the Novavax XBB1.5 vaccine to ward off the risk of infection. In fact, the Novavax XBB1.5 vaccine can induce the immune system to fight against nearly 10 new coronavirus strains, and its relatively broad range The mechanism of immune induction makes it the first choice for vaccine administration. Taiwan also purchased the Novavax XBB1.5 vaccine last year, encouraging the public to use vaccines to prevent the risk of infection during the season of both the new coronavirus and influenza viruses.

Do I need to get vaccinated if the confirmed symptoms are not serious? Taiwan Centers for Disease Control recommends that the following groups should be vaccinated

In view of the mild symptoms of the new coronavirus variant XBB.1.5, many people believe that vaccination is not necessary. However, the recent diagnosis survey report from the Centers for Disease Control and Prevention shows that the global COVID-19 diagnosis rate has reached a new high, indicating that The infectiousness of the virus remains high, and the upcoming Spring Festival will drive the flow of people from Taiwan and abroad, which may trigger a new wave of infection peaks.

The Ministry of Health and Welfare recommends that children with weak immune systems, the elderly, those with immunocompromised diseases, and patients with chronic diseases should be vaccinated to reduce the occurrence of moderate to severe symptoms through vaccine protection. Studies have confirmed that Novavax XBB1.5 vaccine can activate T cells of the immune system and induce a variety of immune cells to respond to XBB.1.5, XBB.1.16, XBB.2.3, JN.1, BA.2.86, EG.5.1, FL. 1.5.1 and XBB.1.16.6 and other mutant strains for immune response. In the face of the continued mutation of the virus, the administration of Novavax XBB1.5 vaccine is expected to become the first line of defense for high-risk groups.

How to choose the COVID-19 XBB vaccine? What everyone must know about epidemic prevention

The XBB variant virus that has been prevalent in Taiwan recently is considered to have a high degree of “immune evasion” that can cause secondary infection. Therefore, the government continues to promote and encourage the public to take XBB-related vaccines to enhance self-protection. Currently, Moderna is available on the market. (Moderna) XBB.1.5 vaccine and Novavax XBB.1.5 are the main ones. As of mid-January, 1.082 million people have been vaccinated with XBB vaccine.

The differences between the two vaccines that also have XBB.1.5 defense can be evaluated from the side effects of vaccination. Side effects of varying degrees usually occur due to individual differences, with symptoms such as fatigue, muscle soreness, increased body temperature, and general weakness being the main symptoms. The Moderna vaccine, which is a type of mRNA, has relatively obvious side effects, and a very small number of cases may develop symptoms such as myocarditis. Therefore, people who have experienced significant side effects from the Moderna vaccine in the past can choose to take the Novavax vaccine, which has milder side effects. . However, for children under the age of 12, only the Moderna XBB vaccine can currently be administered.

On the eve of the annual holiday and the Spring Festival, people who are willing to get vaccinated can check the “Autumn and Winter Vaccine Zone” of the Department of Disease Control and Prevention of the Ministry of Health and Welfare to check the vaccination locations in each county and city. The current COVID-19 XBB vaccine is a publicly funded vaccine. You only need to bring your health insurance card and ID. Once you have the certificate, you can go to the relevant institution to complete the vaccination.

Source: The COVID-19 epidemic is on the rise slightly, and the third phase of Moderna’s XBB.1.5 vaccine has begun. People are asked to get vaccinated as soon as possible to reduce the risk of severe illness and death and protect the health of themselves and their families.

The start of Novavax administration has led to a 33% increase in the number of XBB vaccine doses. 165,000 doses have been inspected and released by the Taiwan Food and Drug Administration today and will be distributed next Tuesday. Both brands of XBB vaccines are safe and effective. Please get vaccinated.

The number of XBB vaccine vaccinations in a single day has reached a new high of 30,000. The supply of Novavax vaccine has been delayed due to abnormal temperatures. 165,000 doses are expected to be delivered next week. The supply of Moderna vaccine is normal and is equally safe and effective. The public is urged to prioritize vaccination as soon as possible.


Further reading:

Cases of “childhood white lung” continue to surge around the world! Critical care doctors call on parents: Only by doing “two things” can epidemic prevention be more effective

Can I choose the brand of flu vaccine? Which ethnic groups can be vaccinated at public expense? Understand the “6 major questions” about influenza vaccines at once

Related Articles: